Rchr
J-GLOBAL ID:201701011452875880
Update date: Nov. 08, 2024
Ando Ryosuke
アンドウ リョウスケ | Ando Ryosuke
Affiliation and department:
Research field (3):
Hygiene and public health (laboratory)
, Healthcare management, medical sociology
, Urology
Research theme for competitive and other funds (32):
- 2023 - 2026 人工知能技術を活用した尿路結石の発症予測モデルの構築
- 2022 - 2026 生体内免疫応答と修復機構の統合的解析による尿路結石の病態解明と溶解療法への展開
- 2022 - 2025 シングルセル解析を用いたオートファジー依存型結石抑制遺伝子の同定
- 2020 - 2023 分子生物学・鉱物学・隕石学の融合による尿路結石の形成機序解明と新規予防法の創設
- 2020 - 2023 尿路結石マトリックス蛋白オステオポンチンを標的としたマクロファージ貪食機序の解明
- 2020 - 2023 エピゲノム酵素LSD1の新規阻害剤による骨転移の難治性疼痛に対する新規治療開発
- 2020 - 2023 尿路結石の新規予防法開発を目指したインスリン抵抗性改善に関わる生活習慣の同定
- 2020 - 2023 メタボリックシンドロームにおける細胞接着分子の発現と腎結石促進機序の解明
- 2019 - 2023 温度感受性に抗がん剤を放出する磁性ナノ粒子を用いた新規がん温熱化学療法の開発
- 2019 - 2023 酸化ストレス活性化転写因子Nrf2をターゲットとした尿路結石症予防法の開発
- 2019 - 2023 Development and drug discovery for urolithiasis by integrated analysis of bio-repair mechanisms
- 2018 - 2022 Elucidation of the suppression mechanism and application to preventive treatment by the novel related gene Nnt of urolithiasis
- 2018 - 2022 Development of urinary stone prevention method targeting mitochondrial cyclophilin D
- 2018 - 2022 Development of medication for urolithiasis via selective autophagy
- 2017 - 2020 Elucidation of the mechanism of the kidney stone formation related by kidney differentiation inducing factor and its application to treatment
- 2017 - 2020 Molecular mechanisms for prostate cancer prevention induced by natural flavonoid
- 2017 - 2020 Development of gene therapy for invasive bladder cancer focusing on genomic instability
- 2017 - 2020 Prognostic analysis of ADC level in MRI for localized bladder carcinoma patients.
- 2017 - 2020 Basic research for elucidation of growth mechanism of testicular tumor by LSD1 and development of therapeutic method by its inhibitor
- 2016 - 2019 Identification of factors involved in formation and elimination of urinary stones and development of new risk diagnosis and prevention methods
- 2016 - 2019 A basic research for novel treatment for castration resistant prostate cancer via LSD1 and autophagy
- 2016 - 2019 Impact of insulin resistance on prostate cancer in Japanese men: A prospective cohort study
- 2016 - 2018 Elucidation of epigenome-mediated proliferation mechanism in bladder cancer and development of therapy with novel inhibitors
- 2015 - 2018 Elucidation of the pathology of mitochondrial injury during urinary calculi formation and development of prevention.
- 2015 - 2018 Development of new therapies for high-risk superficial and invasive bladder cancer by MCL thermotherapy
- 2015 - 2018 Basic research for clinical application of new thermal therapy to inject magnetic nano-particles into cancer metastasis via IVR technology
- 2015 - 2018 Elucidation of the mechanism of urinary stone formation in metabolic syndrome and its application to molecular target treatment
- 2014 - 2017 Establishment of diagnostic markers for recuccent stone disease by genome-wide associated analysis.
- 2014 - 2017 Establishment of the new strategy targeted to intracellular communication mechanism in castration resistant prostate cancer
- 2013 - 2016 Impact of insulin resistance on kidney stones in the Japanese population
- 2013 - 2016 Development of the selective hyperthermia for the bone metastasis of prostate cancer using anti RANKL antibody-binding nanoparticles
- 2011 - 2012 Interactions between diet and peroxisome proliferator-activated receptor-gamma gene Pro12Ala and C161T polymorphisms on prostate cancer risk in Japanese men
Show all
Papers (359):
-
Takashi Nagai, Toshiki Etani, Nobuhiko Shimizu, Masakazu Gonda, Maria Aoki, Toshiharu Morikawa, Shoichiro Iwatsuki, Kazumi Taguchi, Taku Naiki, Kentaro Mizuno, et al. Learning curve of multiple surgeons for robot-assisted radical prostatectomy using the cumulative sum method: a retrospective single-institution study. Journal of robotic surgery. 2024. 18. 1. 389-389
-
Teruki Isobe, Taku Naiki, Yosuke Sugiyama, Aya Naiki-Ito, Takashi Nagai, Toshiki Etani, Keitaro Iida, Yusuke Noda, Nobuhiko Shimizu, Maria Aoki, et al. Experience and prognostic analysis with avelumab switch maintenance treatment in metastatic urothelial carcinoma. Oncology. 2024
-
Takahiro Yanase, Kazumi Taguchi, Teruaki Sugino, Yasuhito Sue, Masahiko Isogai, Tatsuya Hattori, Ryosuke Chaya, Tomoki Okada, Kengo Kawase, Rei Unno, et al. Defining a learning curve for urology trainees to achieve renal access without complications in endoscopic combined intrarenal surgery. International journal of urology : official journal of the Japanese Urological Association. 2024
-
Toshiharu Morikawa, Taku Naiki, Yosuke Sugiyama, Aya Naiki-Ito, Takashi Nagai, Toshiki Etani, Keitaro Iida, Teruki Isobe, Yusuke Noda, Nobuhiko Shimizu, et al. C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study. Cancers. 2024. 16. 9
-
Tomoki Okada, Atsushi Okada, Hiromasa Aoki, Daichi Onozato, Taiki Kato, Hiroshi Takase, Shigeru Ohshima, Teruaki Sugino, Rei Unno, Kazumi Taguchi, et al. Phagocytosis model of calcium oxalate monohydrate crystals generated using human induced pluripotent stem cell-derived macrophages. Urolithiasis. 2024. 52. 1
more...
MISC (260):
-
内木拓, 杉山洋介, 森川敏治, 磯部輝紀, 清水伸彦, 野田祐介, 永井隆, 惠谷俊紀, 青木マリア, 権田将一, et al. 転移性尿路上皮癌に対する3次治療施行症例の後方視的解析. 日本泌尿器科学会中部総会プログラム・抄録集. 2023. 73rd
-
磯部輝紀, 内木拓, 杉山洋介, 清水伸彦, 野田祐介, 永井隆, 惠谷俊紀, 青木マリア, 権田将一, 森川敏治, et al. IO治療導入における転移性尿路上皮癌治療予後の変遷. 日本泌尿器科学会中部総会プログラム・抄録集. 2022. 72nd
-
杉野輝明, 浜本周造, 鬼頭拓未, 森川敏治, 磯谷正彦, 須江保仁, 服部竜也, 海野怜, 田口和己, 安藤亮介, et al. ECIRSにおける開脚腹臥位と修正Valdivia位の無作為化比較試験. 日本泌尿器科学会中部総会プログラム・抄録集. 2022. 72nd
-
青木マリア, 内木拓, 磯部輝紀, 権田将一, 冨山奈美, 清水伸彦, 野田祐介, 永井隆, 惠谷俊紀, 飯田啓太郎, et al. 術前化学療法前後における骨格筋変化量は膀胱全摘症例の予後予測因子である. 日本癌治療学会学術集会(Web). 2022. 60th
-
Kazumi Taguchi, Shuzo Hamamoto, Satoshi Osaga, Teruaki Sugino, Rei Unno, Ryosuke Ando, Atsushi Okada, Takahiro Yasui. Comparison of antegrade and retrograde ureterolithotripsy for proximal ureteral stones: A systematic review and meta-analysis. Translational Andrology and Urology. 2021. 10. 3. 1179-1191
more...
Return to Previous Page